FDA changes labeling for opiate addiction drug.
D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D000075202:Contraindications; D004348:Drug Labeling; D006801:Humans; D008692:Methadyl Acetate / Q000009:adverse effects*; D009294:Narcotics / Q000009:adverse effects*; D009293:Opioid-Related Disorders / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D009294:Narcotics; D008692:Methadyl Acetate